EPISODE · Oct 22, 2025 · 1H 3M
#24 Trauma III: Psychotherapy and Medication Treatments for PTSD
from Good Enough Shrink · host Dr. Jenna Cheng, Dr. Patrick Kelly
Hello listeners! We are so excited to share this episode with you. We get into the nitty gritty of treatment for PTSD in both psychotherapy and medications. **This information is for general knowledge and does not substitute for professional medical advice, diagnosis, or treatment. Please always consult your own healthcare provider for your care.**PsychotherapyTrauma-Focused CBTEMDRCPT, Prolonged Exposure, Narrative Exposure, Psychoanalytic psychotherapy (very brief, this shall be its own episode!)Somatic TherapyMedicationsSSRIs: sertraline (Zoloft), fluoxetine (Prozac), paroxetine (Paxil)SNRIs: CymbaltaAlpha 1 antagonists: prazosinBeta-Blockers: propranolol2nd Generation Antipsychotics: risperidone (Risperdal), quetiapine (Seroquel)Other antidepressants: trazodone, TCAs, MAOIs, zuranolone, lamotrigine, Topamax Interventional PsychiatryTMSVNSNeurofeedbackHallucinogens & Psychedelics KetaminePsilocybin, MDMALSD, ayahuascaMedications NOT RecommendedBenzodiazepinesHigh-dose stimulantsNovel ResearchHydrocortisone & neuroinflammationOpioids & pain controlPTSD Treatment Decision Aid by the VA: https://www.ptsd.va.gov/apps/decisionaid/Have questions for us, or feedback about our podcast? Send us a message!
What this episode covers
Hello listeners! We are so excited to share this episode with you. We get into the nitty gritty of treatment for PTSD in both psychotherapy and medications. **This information is for general knowledge and does not substitute for professional medical advice, diagnosis, or treatment. Please always consult your own healthcare provider for your care.** Psychotherapy Trauma-Focused CBTEMDRCPT, Prolonged Exposure, Narrative Exposure, Psychoanalytic psychotherapy (very brief, this shal...
NOW PLAYING
#24 Trauma III: Psychotherapy and Medication Treatments for PTSD
No transcript for this episode yet
Similar Episodes
May 26, 2022 ·15m
Apr 28, 2022 ·8m